SELLAS Life Sciences Group

SELLAS Life Sciences Group

SLS· Manufacturing· Fiscal year ends in December

CEO pay in FY2022Stock -57.3% in FY2022

Angelos M. Stergiou, M.D., Sc.D. h.c. is the CEO of SELLAS Life Sciences Group and was paid $2.0M in FY2022 (Dec).

Pay$100 in the stock at the end of FY21 → $43
CEO pay is from each SELLAS Life Sciences Group proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Angelos M. Stergiou, M.D., Sc.D. h.c.FY2022
  2. 2Dragan Cicic, M. D.FY2023
  3. 3John T. BurnsNot disclosed

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

SELLAS Life Sciences Group paid its one named executive on file $778.5K in FY2023 (Dec).

Name
Dragan Cicic, M. D.Senior Vice President, Chief Development OfficerNot disclosed
Angelos M. Stergiou, M.D., Sc.D. h.c.President and Chief Executive OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of SELLAS Life Sciences Group names 17 peer companies for pay. Among SELLAS Life Sciences Group and these peers, CEO pay was the lowest of 4 and total shareholder return was the lowest of 4.

4th highest of 4in SELLAS Life Sciences Group and its pay peers, FY2025 (Dec) by CEO pay:

$1.9M$7.0M

4th highest of 4in SELLAS Life Sciences Group and its pay peers, FY2025 (Dec) by total shareholder return:

$160$906

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Robert L. Van NostrandDirector · 8 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

No new filings about this company in the feed.

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KMar 19, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KMar 20, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data